{"disease":{"id":"anti-n-methyl-d-aspartate-receptor-encephalitis","name":"anti n methyl d aspartate receptor encephalitis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06023160","title":"Predicting Functional Outcome and Response to Therapy of Anti-NMDAR Encephalitis at Diagnosis","phase":"","overall_status":"COMPLETED","enrollment_count":714,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT06867991","title":"Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"The First People's Hospital of Changzhou","has_results":false},{"nct_id":"NCT05280600","title":"Developing Advanced Neuroimaging for Clinical Evaluation of Autoimmune Encephalitis","phase":"","overall_status":"UNKNOWN","enrollment_count":75,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT07093333","title":"A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Antibody-Associated Psychiatric Disease","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Arialys Australia Pty Ltd","has_results":false},{"nct_id":"NCT06510283","title":"Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT06753955","title":"Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy Participants","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6,"lead_sponsor_name":"Arialys Therapeutics","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}